Bureau of Infectious Disease Prevention, Michigan Department of Health and Human Services, Lansing, MI, USA
Sara McNamara
Affiliation:
Bureau of Infectious Disease Prevention, Michigan Department of Health and Human Services, Lansing, MI, USA
Kimberly McCullor
Affiliation:
Bureau of Laboratories, Michigan Department of Health and Human Services, Lansing, MI, USA
Marty Soehnlen
Affiliation:
Bureau of Laboratories, Michigan Department of Health and Human Services, Lansing, MI, USA
Davina Campbell
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Amy S. Gargis
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Alison L. Halpin
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Maria Karlsson
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Maroya Spalding Walters
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
D. Cal Ham
Affiliation:
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Cong, Y, Yang, S, Rao, X.Vancomycin resistant Staphylococcus aureus infections: a review of cse updating and clinical features. J Adv Res2020;21:169–176.10.1016/j.jare.2019.10.005CrossRefGoogle Scholar
2
Walters, M, Lonsway, D, Rasheed, K, et al.Investigation and Control of Vancomycin-Resistant Staphylococcus Aureus: A Guide for Health Departments and Infection Control Personnel. Atlanta, GA: CDC; 2015.Google Scholar
3
CDC. Strategies for Conserving the Supply of all Personal Protective Equipment in Healthcare. www.cdc.gov/niosh/healthcare/hcp/pandemic/conserving-PPE.html. Published 2024. Accessed May 29, 2025.Google Scholar
4
Kos, VN, Desjardins, CA, Griggs, A, et al.Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States. mBio2012;3:e00112–12.10.1128/mBio.00112-12CrossRefGoogle ScholarPubMed
5
Klevens, RM, Morrison, MA, Nadle, J, et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA2007;298:1763–1771.10.1001/jama.298.15.1763CrossRefGoogle ScholarPubMed